FDA advisory panel recommends approval of Gardasil to prevent genital warts in young men Bonus Lobbying Victory: European regulators give Gardasil nod for use in women up to the age of 45 Last week was good to Merck's hopes for an improved bottom line next quarter. It was a … [Read more...] about FDA Gifts Merck’s Garasil With Broader Market Access
Fresh controversies are heating up over the marketing of products to prevent cervical cancer The U.S. Food & Drug Administration is gearing up to make critical decisions about two controversial vaccines. On Sept. 9 an FDA advisory committee will consider whether Merck … [Read more...] about Is Merck Overselling a Cancer Vaccine?
I received an email from my ICAP associate, Christina England today. Her message explained a mystery I have been trying to solve for the past week. My site stats have indicated a large number of hits from Russian ISPs and those visitors spending time investigating my article … [Read more...] about ICAP HPV Vaccine Papers Noted in Russian Media
The Future Strategies for Cervical Cancer Prevention: What Do We Need to Do Now to Prepare The Society of Gynecologic Oncologists (SGO) has published the first in a series of four papers on a variety of cervical cancer issues and topics that were the focus of its Forum "The … [Read more...] about Society Of Gynecologic Oncologists Issues White Paper On HPV Vaccine’s Impact On Cervical Cancer Prevention
If A Girl Gets a Gardasil Shot, When Should She Get It? Merck's HPV vaccine, Gardasil, was approved by the FDA and endorsed by the Center for Disease Control (CDC) in June of 2006. According to the Merck marketing literature, the $360, three shot-series of Gardasil, … [Read more...] about If the Goal Is to Prevent Cervical Cancer…Are School Girls The Right Age Group For The HPV Vaccine?